Serodiagnosis of Mycobacterium Tuberculosis Infections

Serodiagnosis of Mycobacterium tuberculosis (M. tuberculosis) relies on the detection of host antibodies generated in response to specific mycobacterial antigens. Unlike bacteriological methods that seek the organism itself, serological assays probe humoral immunity, offering the potential for rapid, nonsputum-based testing. Key approaches include enzyme-linked immunosorbent assays (ELISAs), multiplex bead arrays and microarray platforms configured to present panels of recombinant proteins or synthetic peptides. These assays target both active tuberculosis (ATB) and latent tuberculosis infection (LTBI), aiming to distinguish between disease states by measuring antibody classes (IgG, IgM, IgA) or cytokine-induced biomarkers. Advances in antigen selection—embracing multi-epitope constructs, antigen combinations and novel targets identified by immunoproteomics—have improved diagnostic performance, though sensitivity and specificity remain variable across geographic regions and patient populations. Point-of-care formats seek to integrate rapid readouts with minimal instrumentation, addressing the need for decentralised screening in resource-limited settings. Despite promise, heterogeneity of antibody responses and cross-reactivity with environmental mycobacteria continue to challenge the implementation of serodiagnostics as stand-alone tests. Current efforts concentrate on optimising antigen panels, refining statistical classifiers and integrating serological data with host biomarkers to enhance accuracy and clinical utility.

Research from Nature Portfolio

Recent studies have demonstrated the utility of microchip-based platforms for ultrafast detection of anti-mycobacterial IgG. By employing bead-based ELISA on a magnet actuated chip, researchers achieved multiplexed detection of antibodies against cell-wall components within 15 minutes. The platform showed superior sensitivity in smear-positive and smear-negative ATB samples compared with conventional microscopy, validating its potential as a screening tool at the point of care.

High-density proteome screening using nucleic acid programmable protein arrays has uncovered new immunoreactive M. tuberculosis proteins. A panel of novel antigens was identified by probing patient sera on arrays representing hundreds of recombinant proteins. Subsequent combination of the most robust markers into a multi-antigen assay delivered improved sensitivity and specificity relative to commercial kits, illustrating the power of proteomic discovery in refining serological diagnostics.

Serodiagnosis of Mycobacterium Tuberculosis Infections publication trend

The graph below shows the total number of articles in serodiagnosis of mycobacterium tuberculosis infections across all publications each year (not limited to Nature Index journals).

Technical terms

Serodiagnosis: Diagnosis based on detection of pathogen-specific antibodies in serum.

Active tuberculosis (ATB): Clinical disease state characterised by symptomatic infection and often positive bacteriological tests.

Latent tuberculosis infection (LTBI): Asymptomatic state in which M. tuberculosis persists without causing active disease, typically with negative or low-grade bacteriological findings.

Epitope: Specific amino acid sequence or structure on an antigen recognised by an antibody or T-cell receptor.

Enzyme-linked immunosorbent assay (ELISA): Plate-based assay that quantifies antibodies or antigens via enzyme-mediated colourimetric readout.

Sensitivity and Specificity: Metrics of diagnostic accuracy; sensitivity measures true positive rate, specificity measures true negative rate.

References

1. Microchip-based ultrafast serodiagnostic assay for tuberculosis. Scientific Reports (2016).
2. Identification of Antibody Targets for Tuberculosis Serology using High-Density Nucleic Acid Programmable Protein Arrays*. Molecular & Cellular Proteomics (2017).
3. Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection. Molecular Biomedicine (2024).
4. Discovery of Novel Transketolase Epitopes and the Development of IgG-Based Tuberculosis Serodiagnostics. Microbiology Spectrum (2023).